Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Prevention and treatment strategies used for the community management of childhood fever in Kampala, Uganda.
Kemble, SK; Davis, JC; Nalugwa, T; Njama-Meya, D; HOPKINS, H; Dorsey, G; STAEDKE, SG;
2006
The American journal of tropical medicine and hygiene, (2006).74 6 10.4269/ajtmh.2006.74.999.
Beijing/W Genotype<i>Mycobacterium tuberculosis</i>and Drug Resistance.
GLYNN, JR; Kremer, K; Borgdorff, MW; Rodriguez, MP; Van Soolingen, D;
2006
Emerging infectious diseases, (2006).12 5 10.3201/eid1205.050400.
Short report: Dynamics of Plasmodium falciparum malaria after sub-optimal therapy in Uganda.
Myrick, A; Leemann, E; Dokomajilar, C; HOPKINS, H; Dorsey, G; Kamya, MR; Rosenthal, PJ;
2006
The American journal of tropical medicine and hygiene, (2006).74 5 10.4269/ajtmh.2006.74.758.
Isoniazid preventive therapy and risk for resistant tuberculosis.
Balcells, ME; THOMAS, SL; GODFREY-FAUSSETT, P; GRANT, AD;
2006
Emerging infectious diseases, (2006).12 5 10.3201/eid1205.050681.
Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
Pinder, M; SUTHERLAND, CJ; Sisay-Joof, F; Ismaili, J; McCall, MB B; Ord, R; Hallett, R; Holder, AA; MILLIGAN, P;
2006
Infection and immunity, (2006).74 5 10.1128/IAI.74.5.2887-2893.2006.
Current scenario of drug development for leishmaniasis.
CROFT, SL; SEIFERT, K; YARDLEY, V;
2006
The Indian journal of medical research, (2006).123 3
Current issues for anti-malarial drugs to control P. falciparum malaria.
SCHELLENBERG, D; Abdulla, S; ROPER, C;
2006
Current molecular medicine, (2006).6 2 10.2174/156652406776055168.
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.
Pérez-Victoria, FJ; Sánchez-Cañete, MP; SEIFERT, K; CROFT, SL; Sundar, S; Castanys, S; Gamarro, F;
2006
Drug resistance updates, (2006).9 1-2 10.1016/j.drup.2006.04.001.
Drug resistance in leishmaniasis.
CROFT, SL; Sundar, S; Fairlamb, AH;
2006
Clinical microbiology reviews, (2006).19 1 10.1128/CMR.19.1.111-126.2006.
Disentangling value: assessing the benefits of containing antimicrobial resistance.
Coast, J; SMITH, R; Millar, M;
2006
The Economics of Infectious Disease , OUP International (New York) (2006).